© 2005 European Society of Cardiology
Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis
a Population Health Research Institute, McMaster University, and Hamilton Health Sciences Hamilton, Ontario, Canada
b Cardiology Department, S. Raffaele Hospital Milan, Italy
c Division of Cardiology, McMaster University Hamilton, Ontario, Canada
d Department of Epidemiology and Biostatistics, McMaster University Hamilton, Ontario, Canada
* Corresponding author. Viale Abruzzi, 90, 20131 Milan, Italy. Tel./fax: +39 02 29512491. E-mail address: rosaroccaforte{at}hotmail.com
 |
Abstract |
|---|
Background: Disease management programmes (DMP) have been advocated to improve long term outcomes of heart failure (HF) patients.
Aims: To summarise the evidence supporting DMP effectiveness in improving HF clinical outcomes.
Methods: Eligible studies were located through a systematic literature search. Only randomised controlled trials (RCTs), enrolling HF patients, and allocating them to DMP or usual care (UC), were included. Information on study setting and design, participants' characteristics and interventions tested were collected. A study quality assessment was performed. Main clinical outcomes assessed were: all-cause mortality and (re)hospitalisations, HF-related (re)hospitalisations and mortality. Meta-analysis was performed according to both Yusuf–Peto method and random effects model.
Results: Thirty-three RCTs were included. Mortality was significantly reduced by DMP compared to UC: OR = 0.80 (CI 0.69–0.93, p=0.003). All-cause and HF-related hospitalisation rates were also significantly reduced: OR=0.76 (CI 0.69–0.94, p<0.00001) and OR=0.58 (CI 0.50–0.67, p<0.00001), respectively. Different DMP approaches appeared to be equally effective (sensitivity analyses).
Conclusion: DMP reduce mortality and hospitalisations in HF patients. Because various types of DMP appear to be similarly effective, the choice of a specific programme depends on local health services characteristics, patient population, and resources available.
Key Words: Disease management programme • Heart failure • Hospitalisation • Mortality • Meta-analysis
Received June 15, 2005; Accepted August 22, 2005
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Klersy, A. De Silvestri, G. Gabutti, F. Regoli, and A. Auricchio A meta-analysis of remote monitoring of heart failure patients. J. Am. Coll. Cardiol., October 27, 2009; 54(18): 1683 - 1694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Clark, L. A. Savard, and D. R. Thompson What is the strength of evidence for heart failure disease-management programs? J. Am. Coll. Cardiol., July 28, 2009; 54(5): 397 - 401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Gustafsson, M. Schou, L. Videbaek, N. Dridi, H. Ryde, J. Handberg, P. R. Hildebrandt, and on behalf of the Danish Heart Failure Clinics Netw Incidence and predictors of hospitalization or death in patients managed in multidisciplinary heart failure clinics Eur J Heart Fail, April 1, 2009; 11(4): 413 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur. Heart J., October 1, 2008; 29(19): 2388 - 2442. [Full Text] [PDF]
|
|
|
|
|
|
K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, A. W. Hoes, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail, October 1, 2008; 10(10): 933 - 989. [Full Text] [PDF]
|
|
|
|
|
|
A. P. Coletta, J. G.F. Cleland, D. Cullington, and A. L. Clark Clinical trials update from Heart Rhythm 2008 and Heart Failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452 Eur J Heart Fail, September 1, 2008; 10(9): 917 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Bocchi, F. Cruz, G. Guimaraes, L. F. Pinho Moreira, V. S. Issa, S. M. Ayub Ferreira, P. R. Chizzola, G. E. C. Souza, S. Brandao, and F. Bacal Long-Term Prospective, Randomized, Controlled Study Using Repetitive Education at Six-Month Intervals and Monitoring for Adherence in Heart Failure Outpatients: The REMADHE Trial Circ Heart Fail, July 1, 2008; 1(2): 115 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Paul Hospital Discharge Education for Patients With Heart Failure: What Really Works and What Is the Evidence? Crit. Care Nurse, April 1, 2008; 28(2): 66 - 82. [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Webber New-Onset Heart Failure in Children in the Absence of Structural Congenital Heart Disease Circulation, January 1, 2008; 117(1): 11 - 12. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Khunti, M. Stone, S. Paul, J. Baines, L. Gisborne, A. Farooqi, X. Luan, and I. Squire Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial Heart, November 1, 2007; 93(11): 1398 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Gustafsson, M. Schou, L. Videbaek, T. Nielsen, H. Ulriksen, J. Markenvard, T. L. Svendsen, H. Ryde, E. Vigholt, P. Hildebrandt, et al. Treatment with beta-blockers in nurse-led heart failure clinics: Titration efficacy and predictors of failure Eur J Heart Fail, September 1, 2007; 9(9): 910 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G.F. Cleland, A. P. Coletta, and A. L. Clark Clinical trials update from the American College of Cardiology 2007: ALPHA, EVEREST, FUSION II, VALIDD, PARR-2, REMODEL, SPICE, COURAGE, COACH, REMADHE, pro-BNP for the evaluation of dyspnoea and THIS-diet Eur J Heart Fail, June 1, 2007; 9(6-7): 740 - 745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. McDonald, C. Conlon, and M. Ledwidge Disease management programs for heart failure: Not just for the 'sick' heart failure population Eur J Heart Fail, February 1, 2007; 9(2): 113 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G.F. Cleland, A. P. Coletta, and A. L. Clark Clinical trials update from the joint European Society and World Congress of Cardiology meeting: PEP-CHF, ACCLAIM and the HHH study Eur J Heart Fail, October 1, 2006; 8(6): 658 - 661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Stromberg Heart failure management programmes: The time for action has arrived Eur J Heart Fail, December 1, 2005; 7(7): 1077 - 1078. [Full Text] [PDF]
|
|